| Name | Title | Contact Details |
|---|
lcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx`s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMet for Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market. Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians support the team. In September 2013, Elcelyx announced the formation of NaZura BioHealth Inc, a separate company established to focus on the development on non-NewMet assets.
Alternative Careers and Transitions Inc is a Pittsburgh, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Prevention Point Philadelphia is a Philadelphia, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
PaxeraHealth (Formerly Paxeramed) is a leading healthcare solution developer based in Boston, MA. We develop a full range of medical imaging solutions including PACS, RIS, VNA, multi-modality workstations, mobile App viewers, patient portal, dental PACS, Vet PACS, advanced visualization, Patient engagement and enterprise solutions. Leveraging technology and staying at the forefront of new healthcare IT technological developments is a high priority for PaxeraHealth. The company develops the next generation medical imaging and Patient engagement technologies designed to automate clients` workflow, elevate patient care and cut healthcare costs.
Center for Bio-Medical Communication is a Hackensack, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.